Experience with long-term glucocorticoid treatment in congenital adrenal hyperplasia: Growth pattern compared with genetic height potential

AYCAN, ZEHRA; Ocal, G; BERBEROĞLU, MERİH; Cetinkaya, E; Adiyaman, P; EVLİYAOĞLU, Saadet

doi:10.1515/jpem.2006.19.3.245

Experience with long-term glucocorticoid treatment in congenital adrenal hyperplasia: Growth pattern compared with genetic height potential

AYCAN Z., Ocal G., BERBEROĞLU M., Cetinkaya E., Adiyaman P., EVLİYAOĞLU S. O.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, cilt.19, sa.3, ss.245-251, 2006 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 19 Sayı: 3
Basım Tarihi: 2006
Doi Numarası: 10.1515/jpem.2006.19.3.245
Dergi Adı: JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.245-251
Anahtar Kelimeler: congenital adrenal hyperplasia, height development, 21-HYDROXYLASE DEFICIENCY, THERAPY, HORMONE, CHILDREN, IGF
Ankara Üniversitesi Adresli: Evet

Özet

Objective: Long-term replacement treatment with high doses of steroids in congenital adrenal hyperplasia (CAH) is known to have a negative influence on growth. We evaluated the effects of long-term steroid treatment in patients with classical CAH on height development in relation to genetic height potential.